Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers
1 other identifier
interventional
48
3 countries
3
Brief Summary
The purpose of this study is to determine and compare the glycaemic index values and response parameters of 6 food products between 3 laboratories.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 3, 2013
CompletedFirst Posted
Study publicly available on registry
June 6, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedAugust 21, 2014
August 1, 2014
5 months
June 3, 2013
August 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine and Perform Inter-Laboratory Comparison of Glycaemic Index Values of 6 Food Products
0-120 minutes
Secondary Outcomes (9)
Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products
0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products
0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products
0-120 minutes
Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products
0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products
01-20 minutes
- +4 more secondary outcomes
Study Arms (7)
Reference Glucose
OTHERGlucose Standard (50g of Glucose)
Food Product A: Corn Flakes
EXPERIMENTALCorn Flakes
Food Product B: Ginger Bread
EXPERIMENTALGinger Bread
Food Product C:Sandwiched Breakfast Biscuit
EXPERIMENTALSandwiched Breakfast Biscuit
Food Product D: Crackers Nature
EXPERIMENTALCrackers Nature
Food Product E: Breakfast Biscuit
EXPERIMENTALBreakfast Biscuit
Food Product F: White Bread
EXPERIMENTALWhite Bread
Interventions
Eligibility Criteria
You may qualify if:
- Aged 18-35 years inclusive.
- Non-smoker.
- BMI 19.0-25.0 kg/m2 inclusive.
- Healthy subjects with:
- Fasting plasma glucose \< 5,6 mM (ADA criteria,2011)
- Insulin resistance index based on homeostasis model assessment (HOMA-IR) \<1.70
- Fasting lipids: triglyceride \<1.70mmol/L, LDL-cholesterol\<5.00 mmol/L and HDL-cholesterol \>1.03mmol/L for males or \>1.29mmol/L for females (IDF criteria for metabolic syndrome, 2006)
- Gamma-GT, AST and ALT \<1.5 times the upper limit of normal (ULN)
- Complete blood count: Normal full blood count according to the investigator
- Systolic blood pressure \<130 mmHg
- Diastolic blood pressure \<85 mmHg
- Resting heart rate 50-90 beats per minutes (after 3 minutes rest).
- Stable dietary habits; normal eating patterns; no history of eating disorders or strict dieting.
- Moderate level of physical activity (from basic daily activity to a high level of physical activity (regular physical activity at least 3 times per week))
- Able to fast for at least 10 hours the night before each test session.
- +4 more criteria
You may not qualify if:
- Following a restrictive or specific diet.
- Suffering from any inflammatory or metabolic diseases
- Suffering from mental illness.
- Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc).
- Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive.
- Subject having taken part in another clinical trial within the last week.
- Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mondelēz International, Inc.lead
- BioFortiscollaborator
- Glycemic Index Laboratories, Inccollaborator
- University of Sydneycollaborator
Study Sites (3)
Human Nutrition Unit, The University of Sydney
Sydney, 2006, Australia
Glycemic Index Laboratories
Toronto, Ontario, M5C 2N8, Canada
Biofortis
Saint-Herblain, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Gendre, Dr.
BioFortis
- PRINCIPAL INVESTIGATOR
Thomas Wolever, Dr.
Glycemic Index Laboratories, Inc
- PRINCIPAL INVESTIGATOR
Jennie Brand Miller, Dr.
University of Sydney
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2013
First Posted
June 6, 2013
Study Start
June 1, 2013
Primary Completion
November 1, 2013
Study Completion
December 1, 2013
Last Updated
August 21, 2014
Record last verified: 2014-08